| |
| |
|
| Insider
Information: |
Mcfarlane Neil F. |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
68,660 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,736,535 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
68,660 |
|
|
| Total
Value |
$1,736,535 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
Chief Operating Officer |
2019-05-16 |
26,988 |
2016-08-15 |
0 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Chief Executive Office... |
2021-11-24 |
0 |
2019-09-16 |
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2023-05-18 |
41,672 |
2022-04-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
41,672 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
31,880 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,845 |
17,845 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(600,000) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-24 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
600,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
525,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
225,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2019-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2019-05-16 |
4 |
AS |
$18.71 |
$18,411 |
D/D |
(984) |
26,988 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2019-05-15 |
4 |
AS |
$17.78 |
$17,496 |
D/D |
(984) |
27,972 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-12-20 |
4 |
AS |
$22.00 |
$248,333 |
D/D |
(11,125) |
28,956 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,125 |
40,081 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-11-14 |
4 |
AS |
$23.63 |
$237,314 |
D/D |
(10,000) |
28,476 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,476 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
27,948 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,546 |
17,448 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2017-08-16 |
4 |
S |
$22.50 |
$31,005 |
D/D |
(1,378) |
13,622 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Operating Officer |
• – – |
2016-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
